According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...

Following three years of internal development, Expedition Medicines is taking flight. The company is supported by a $50 ...

Natural products derived from microorganisms are a promising source of new active ingredients, but are often produced only in ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

The U.S. Cell-based Assays Market is Expanding Rapidly Due to Strong Pharmaceutical Activity, Technological Innovation, and Increasing Use in Drug Discovery and Toxicity Testing.Austin, Oct. 30, 2025 ...

WuXi AppTec, a global contract research, development, and manufacturing organization (CRDMO), recently hosted its 2025 ...

Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten ...

SandboxAQ, a U.S.-based artificial intelligence and quantum technology firm, signed an agreement with Bahrain's sovereign ...

The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity ...

On October 27, Thermo Fisher Scientific and Lundbeck both announced new collaborations with OpenAI. These moves represent a continuing trend of drug development companies inking deals with technology ...